134 related articles for article (PubMed ID: 11688968)
21. Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer.
Okumura K; Shiomi H; Mekata E; Kaizuka M; Endo Y; Kurumi Y; Tani T
Oncol Rep; 2006 Apr; 15(4):875-82. PubMed ID: 16525674
[TBL] [Abstract][Full Text] [Related]
22. Enhancement of fluorouracil uptake in human colorectal and gastric cancers by interferon or by high-dose methotrexate: An in vivo human study using noninvasive (19)F-magnetic resonance spectroscopy.
Presant CA; Wolf W; Waluch V; Wiseman CL; Weitz I; Shani J
J Clin Oncol; 2000 Jan; 18(2):255-61. PubMed ID: 10637237
[TBL] [Abstract][Full Text] [Related]
23. Prediction of chemotherapeutic response of colorectal liver metastases with dynamic gadolinium-DTPA-enhanced MRI and localized 19F MRS pharmacokinetic studies of 5-fluorouracil.
van Laarhoven HW; Klomp DW; Rijpkema M; Kamm YL; Wagener DJ; Barentsz JO; Punt CJ; Heerschap A
NMR Biomed; 2007 Apr; 20(2):128-40. PubMed ID: 17006886
[TBL] [Abstract][Full Text] [Related]
24. Results of pharmacokinetic modulating chemotherapy in combination with hepatic arterial 5-fluorouracil infusion and oral UFT after resection of hepatic colorectal metastases.
Kusunoki M; Yanagi H; Noda M; Yoshikawa R; Yamamura T
Cancer; 2000 Sep; 89(6):1228-35. PubMed ID: 11002217
[TBL] [Abstract][Full Text] [Related]
25. Technetium-99m HL91 uptake as a tumour hypoxia marker: relationship to tumour blood flow.
Tatsumi M; Yutani K; Kusuoka H; Nishimura T
Eur J Nucl Med; 1999 Feb; 26(2):91-4. PubMed ID: 9933342
[TBL] [Abstract][Full Text] [Related]
26. Weichang'an and 5-fluorouracil suppresses colorectal cancer in a mouse model.
Tao L; Yang JK; Gu Y; Zhou X; Zhao AG; Zheng J; Zhu YJ
World J Gastroenterol; 2015 Jan; 21(4):1125-39. PubMed ID: 25632185
[TBL] [Abstract][Full Text] [Related]
27. Regional chemotherapy for colorectal liver metastases: a phase II evaluation of targeted hepatic arterial 5-fluorouracil for colorectal liver metastases.
Goldberg JA; Kerr DJ; Wilmott N; McKillop JH; McArdle CS
Br J Surg; 1990 Nov; 77(11):1238-40. PubMed ID: 2253002
[TBL] [Abstract][Full Text] [Related]
28. Influence of the administration of amifostine on the pharmacokinetics of 5-fluorouracil in patients with metastatic colorectal carcinoma.
Martens-Lobenhoffer J; Fuhlroth J; Ridwelski K
Int J Clin Pharmacol Ther; 2000 Jan; 38(1):41-4. PubMed ID: 10667836
[TBL] [Abstract][Full Text] [Related]
29. Oral Recombinant Methioninase Overcomes Colorectal-cancer Liver Metastasis Resistance to the Combination of 5-Fluorouracil and Oxaliplatinum in a Patient-derived Orthotopic Xenograft Mouse Model.
Oshiro H; Tome Y; Kiyuna T; Yoon SN; Lwin TM; Han Q; Tan Y; Miyake K; Higuchi T; Sugisawa N; Katsuya Y; Park JH; Zang Z; Razmjooei S; Bouvet M; Clary B; Singh SR; Kanaya F; Nishida K; Hoffman RM
Anticancer Res; 2019 Sep; 39(9):4667-4671. PubMed ID: 31519565
[TBL] [Abstract][Full Text] [Related]
30. [Concentration of 5-FU after hepatic artery infusion chemotherapy for liver metastases of colorectal cancer].
Maruyama S; Ando M; Watayo T
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1635-8. PubMed ID: 14619482
[TBL] [Abstract][Full Text] [Related]
31. 5-FU uptake in peritoneal metastases after pretreatment with radioimmunotherapy or vasoconstriction: an autoradiographic study in the rat.
Mahteme H; Sundin A; Larsson B; Khamis H; Arow K; Graf W
Anticancer Res; 2005; 25(2A):917-22. PubMed ID: 15868928
[TBL] [Abstract][Full Text] [Related]
32. Issues of normal tissue toxicity in patient and animal studies--effect of carbogen breathing in rats after 5-fluorouracil treatment.
Griffiths JR; McIntyre DJ; Howe FA; McSheehy PM; Ojugo ASE ; Rodrigues LM; Wadsworth P; Price NM; Lofts F; Nicholson G; Smid K; Noordhuis P; Peters GJ; Stubbs M
Acta Oncol; 2001; 40(5):609-14. PubMed ID: 11669333
[TBL] [Abstract][Full Text] [Related]
33. Bioavailability of subcutaneous 5-fluorouracil: a case report.
Eatock MM; Carlin W; Dunlop DJ; Soukop M; Watson DG
Cancer Chemother Pharmacol; 1996; 38(1):110-2. PubMed ID: 8603444
[TBL] [Abstract][Full Text] [Related]
34. Drug monitoring of 5-fluorouracil: in vivo 19F NMR study during 5-FU chemotherapy in patients with metastases of colorectal adenocarcinoma.
Schlemmer HP; Bachert P; Semmler W; Hohenberger P; Schlag P; Lorenz WJ; van Kaick G
Magn Reson Imaging; 1994; 12(3):497-511. PubMed ID: 8007780
[TBL] [Abstract][Full Text] [Related]
35. Development of new promising antimetabolite, DFP-11207 with self-controlled toxicity in rodents.
Fukushima M; Iizuka K; Jin C; Zhang C; Hong M; Eshima K
Drug Des Devel Ther; 2017; 11():1693-1705. PubMed ID: 28652707
[TBL] [Abstract][Full Text] [Related]
36. Biochemical modulation of the catabolism and tissue uptake of the anticancer drug 5-fluorouracil by 5-bromovinyluracil: assessment with metabolic (19)F MR imaging.
Brix G; Bellemann ME; Haberkorn U
Magn Reson Med; 1999 Nov; 42(5):936-43. PubMed ID: 10542353
[TBL] [Abstract][Full Text] [Related]
37. Absorption and distribution characteristics of 5-fluorouracil (5-FU) after an application to the liver surface in rats in order to reduce systemic side effects.
Kodama Y; Fumoto S; Nishi J; Nakashima M; Sasaki H; Nakamura J; Nishida K
Biol Pharm Bull; 2008 May; 31(5):1049-52. PubMed ID: 18451546
[TBL] [Abstract][Full Text] [Related]
38. Biochemical modulation by 5-fluorouracil and 1-folinic acid of tumor uptake of intra-arterial 5-[123I]iodo-2'deoxyuridine in patients with liver metastases from colorectal cancer.
Mariani G; Di Sacco S; Bonini R; Di Luca L; Buralli S; Bonora D; Ricci S; Baranowska-Kortylewicz J; Adelstein SJ; Falcone A; Kassis AI
Acta Oncol; 1996; 35(7):941-5. PubMed ID: 9004775
[TBL] [Abstract][Full Text] [Related]
39. Hepatic fibrosis does not affect the pharmacokinetics of 5-fluorouracil in rats.
Nagata M; Hidaka Y; Hatakeyama K; Kawano Y; Iwakiri T; Okumura M; Arimori K
Biopharm Drug Dispos; 2011 Mar; 32(2):126-30. PubMed ID: 21341281
[TBL] [Abstract][Full Text] [Related]
40. Regional administration of irinotecan in combination with 5-fluorouracil and leucovorin in patients with colorectal cancer liver metastases--a pilot experience.
Melichar B; Dvorák J; Jandík P; Tousková M; Malírová E; Megancová J; Voboril Z
Hepatogastroenterology; 2001; 48(42):1721-6. PubMed ID: 11813608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
